MDalert.com is designed to help physicians in all specialties succeed in this new world of performance-driven healthcare.
December 6, 2022

Cardiovascular Disease, Psoriasis Share ‘common Genetic Origin’ In East Asian And European Populations

By Andrew John, MD /alert Contributor

A recently published literature review and meta-analysis suggests that cardiovascular disease and psoriasis may share the same genetic origin, and that cardiovascular outcomes may be improved with targeted psoriasis therapy...
Click here to read full article
Cardiovascular Disease, Psoriasis Share ‘common Genetic Origin’ In East Asian And European Populations
December 2, 2022

Patients with Alopecia Areata Show Increased Rates of Distressed Personality, Depression, Anxiety

By Andrew John, MD /alert Contributor

Distressed personality, or “Type D” personality, is more common in people with alopecia areata than in those without the condition...
Click here to read full article
Patients with Alopecia Areata Show Increased Rates of Distressed Personality, Depression, Anxiety
December 1, 2022

Fertility Preservation Does Not Increase Risk Of Relapse, Mortality In Women With Breast Cancer

By Michael Vlessides, MD /alert Contributor
Results from a new investigation support the safety of fertility preservation in women with breast cancer...
Click here to read full article
Fertility Preservation Does Not Increase Risk Of Relapse, Mortality In Women With Breast Cancer
November 30, 2022

Rare Success For Alzheimer's Research Unlocks Hope For Future Therapies

By Julie Steenhuysen, Reuters

The first big breakthrough in 30 years of Alzheimer’s research is providing momentum for clinical trials of “cocktail” treatments targeting the two hallmark proteins associated with the mind-robbing disease, according to interviews with researchers and pharmaceutical executives...
Click here to read full article
Rare Success For Alzheimer's Research Unlocks Hope For Future Therapies
November 28, 2022

Factors Unrelated to CAR-T Cells May Influence BCMA Therapy Response in Patients With Myeloma

By Cameron Kelsall, MD /alert Contributor
Changes in the tumor immune microenvironment of patients with multiple myeloma may indicate which patients will achieve durable progression-free survival after treatment with B-cell maturation antigen (BCMA) targeted CAR T-cell therapy...
Click here to read full article
Factors Unrelated to CAR-T Cells May Influence BCMA Therapy Response in Patients With Myeloma
View More
Loading...

Trending News

In cooperation with Reuters News and Reuters Health, we are proud to provide you with our continuously updated news feed. We select news that applies to physicians in all the major clinical specialties, as well as on finance, science, technology, and other areas.

Reuters Health Medical News

INSIGHT-Why world's first malaria shot won't reach millions of children who need it

By Jennifer Rigby, Natalie Grover and Maggie Fick LONDON/KISUMU, Kenya, July 13 (Reuters) - After decades of work, the World Health Organization endorsed the first-ever malaria vaccine last year - a Read More »

See all news »

Featured Video

Migraine Therapy Improves Work Productivity, QoL

Migraine Therapy Improves Work Productivity, QoL

Clinical Trials

Use our ClinicalTrials.gov feed to find trials in which your patients could enroll. In some cases, experimental drugs are a patient’s only hope. This section will regularly report on trials in the most common disease states, as they are getting underway.


© 2022 /alert® unless otherwise noted. All rights reserved.
Reproduction in whole or in part without permission is prohibited.
Privacy Policy | Terms of Use | Editorial Policy | Advertising Policy